Tirzepatide × Unknown Brand — Lab Test, June 2026
COA KVR-2026-214D9F matches Kovera Labs's public record. So this test doesn't rest on our review alone — the lab confirms it too.
P9IOBKHTest results
About this test
Label 17 mg · Lab measured 22.42 mg
132% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 5.6 mg using the measured mass, against 4.3 mg on the label — 32% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | KVR-2026-214D9F |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 27 Jul 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | Kovera Labs's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of Tirzepatide from Unknown brand, performed by Kovera Labs on June 20, 2026. Reported purity: 99.835%. Net content: 22.42 mg against 17 mg labeled (132% of label). Tested content exceeds the labeled amount by 32%. Endotoxins: PASS (≤0.5 EU/mL). Heavy metals: Arsenic <0.15, Cadmium <0.05, Lead <0.5, Mercury <0.3 — all Pass. Batch AMC-TZ17-01. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion